Clinical Study

Is Leukocytosis a Predictor for Recurrence of Ischemic Events after Coronary Artery Bypass Graft Surgery? A Cohort Study

Table 5

Univariate analysis.

Ischemic eventNo ischemic eventOR (95% CI) 𝑃 value

Sex (male)83 (69.7%)198 (75.9%)1.36 (0.84–2.21)0.208
Mean age57.09 (±9.4)57.7 (±9.4)0.51
HTN71 (59.7%)140 (53.6%)1.27 (0.82–1.98)0.27
Smoker52 (50.7%)110 (42.1%)1.065 (0.68–1.65)0.77

Cholesterol
 200–240 mg/dL27 (22.7%)52 (19.9%)1.16 (0.68–2)0.57
 >240 mg/dL20 (16.8%)47 (18%)0.95 (0.52–1.73)0.88
 Diabetes Mellitus16 (13.4%)33 (12.6%)1.07 (0.56–2.03)0.82
 BMI ≥ 2942 (35.9%)61 (23.7%)1.79 (1.11–2.89)0.015

WBC
 ≥6000 mic/lit92 (77.3%)161 (61.7%)2.11 (1.28–3.44)0.003
 Left main >50%13 (10.9%)21 (8%)1.402 (0.67–2.9)0.36
 LAD > 70%106 (89.1%)236 (91%)0.79 (0.38–1.62)0.52

Ejection fraction
 40%–50%51 (40.2%)107 (42.3%)0.84 (0.48–1.48)0.55
 >50%49 (38.6%)89 (32.2%)0.83 (0.46–1.47)0.52
 Family history33 (27.7%)80 (30.7%)0.86 (0.53–1.4)0.56
 Number of graft (mean)2.5 (±0.91)2.58 (±0.82)0.38
 Cr > 1.5 mg/dL8 (6.7%)10 (12.4%)1.809 (0.69–4.7)0.21
 Pump timing (mean)/min43.73 min46.91 min0.59
 CPB (mean)/min243/4 (±91)243 (±86)0.98
 CK.MB47 (±41)43 (±25)0.4
 Logestic EuroScore2.61 (±1.3)2.2 (±1.2)0.01
 Arterial graft85 (87.6%)246 (86.9%)1.06 (0.53–2.1)0.85
 ASA94 (96.9%)273 (96.5%)1.1 (0.3–4.2)0.83
 Beta.blocher79 (81.4%)220 (77.3%)1.2 (0.7–2.2)0.41
 Ace.Inh46 (47.4%)149 (52.7%)0.81 (0.5–1.2)0.37
 CCB11 (11.3%)34 (12%)0.93 (0.45–1.9)0.85
 Statin61 (62.9%)150 (0.53%)1.5 (0.9–2.4)0.09
 Diuretic6 (6.2%)14 (4.9%)1.27 (0.43–3.3)0.63
 Nitriglicerin30 (30.9%)72 (25.4%)1.3 (0.79–2.1)0.29

BMI: Body Mass Index; WBC: White Blood Cell; LAD: Left Anterior Descending; CCB: calcium chanel blocher.